CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,991 | $413.58 | $823K | 2,139 |
| 2025-10-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −509 | $415.02 | $211K | 1,630 |
| 2025-10-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,500 | $417.92 | $627K | 130 |
| 2025-10-28 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 146,000 | ||
| 2025-10-27 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $411.95 | $412K | 3,130 |
| 2025-10-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,814 | $414.42 | $752K | 1,316 |
| 2025-10-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,186 | $420.29 | $498K | 130 |
| 2025-10-27 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 150,000 | ||
| 2025-10-27 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +14,625 | $135.42 | $2.0M | 14,625 |
| 2025-10-27 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −14,625 | $417.50 | $6.1M | 0 |
| 2025-10-27 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +6,125 | $146.03 | $894K | 6,125 |
| 2025-10-27 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +1,750 | $146.03 | $256K | 7,875 |
| 2025-10-27 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −7,875 | $417.50 | $3.3M | 130 |
| 2025-10-27 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −14,625 | 55,875 | ||
| 2025-10-27 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −6,125 | 18,375 | ||
| 2025-10-27 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −1,750 | 0 | ||
| 2025-10-24 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,937 | $423.56 | $1.2M | 1,193 |
| 2025-10-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −563 | $424.64 | $239K | 630 |
Page 189 of 214 · 4,273 trades